|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/10 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61P 25/18 | (2006.01) |
| (11) | Number of the document | 4005555 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21210307.1 |
| Date of filing the European patent application | 2021-11-24 | |
| (97) | Date of publication of the European application | 2022-06-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-15 |
| (46) | Date of publication of the claims translation | 2024-06-25 |
| (30) | Number | Date | Country code |
| 202063119305 P | 2020-11-30 | US | |
| 202163237883 P | 2021-08-27 | US |
| (72) |
D'HOORE, Peter , BE
WALLAERT, Ignace , BE
NGUYEN, Jimmy , US
MEEUSSEN, Frank , BE
GOPAL, Srihari , US
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Paliperidono palmitato vaistinės formos pakartotinio suspendavimo užtikrinimo būdas |
| METHODS FOR ENSURING RESUSPENSION OF PALIPERIDONE PALMITATE FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2024-10-24 | 4 | 92.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-07-03 |